Bahamas vs Malta: Access to anti-retroviral drugs, male
Bahamas
74.0%
in 2024
Malta
74.0%
in 2024
Bahamas rank
58th
Malta rank
58th
Access to anti-retroviral drugs, male over time
- Bahamas
- Malta
How they compare
Bahamas currently reports 74.0% against 74.0% in Malta, a difference of 0.0%.
The two have swapped places 6 times across 25 shared years of data; in 2000 it was Malta ahead.
Bahamas ranks 58th and Malta ranks 58th of 141 countries.
Across the 3 decades both report, Bahamas averaged higher in 2 and Malta in 1.
Head to head by decade
| Decade | Bahamas | Malta | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 16.9% | 21.6% | 4.7% | Malta |
| 2010s | 47.5% | 45.0% | 2.5% | Bahamas |
| 2020s | 71.8% | 65.4% | 6.4% | Bahamas |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Bahamas or Malta?
- Bahamas, at 74.0% against 74.0% in Malta as of 2024.
- What is the difference in access to anti-retroviral drugs, male between Bahamas and Malta?
- 0.0%, with Bahamas ahead.
- How many years of comparable data are there for Bahamas and Malta?
- 25 years are reported by both, from 2000 to 2024.
- How do Bahamas and Malta rank globally for access to anti-retroviral drugs, male?
- Bahamas ranks 58th and Malta ranks 58th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.